NBS closed at $7.47 … UP +$0.82 or +12.33% on strong volume of 663.6 K. As I had been stating NBS has been hitting to right field with 2 and 3 solid base hits. The key after any reverse is the keep swinging with base hits and NBS is delivering for the cell therapy sector. NBS is one of the few with positive catalysts – that stay in the park and we are only in the second inning with multiple batters on deck and base runners on 1st and 3rd.
You wax eloquent again. Smart folks will afford you the credence you deserve. You stated pre-split all of the advantages and predicted this rise. I agreed with you then and I agree with you now. Still holding the stash and adding on dips.